Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Case report: Pregnancy and birth

Von Willebrand syndrome with impressive bleeding history

    • Cases
    • Education
    • Gynecology
    • Hematology
    • RX
  • 3 minute read

A patient who had already suffered four miscarriages related to bleeding complications presents for thrombophilia screening at the 6th week of gestation. During the diagnostic process, Von Willebrand syndrome is detected, which must be taken into account in the course of pregnancy, during delivery and in the puerperium.

Laboratory values
Baseline
(10.12.2018)
23. SSW
(20.03.2019)
29TH SSW
(06.05.2019)
aPTT
26s
25s
24s
FVIII:C
123%
231%
238%
VWF:Ag
106.0%
185.5%
196.8%
VWF:RCo
49.1%
52.8%
60.9%
VWF:CBA
46.0%
53.2%
63.7%
VWF:RCo/VWF:Ag Ratio
0.5
0.3
0.3
Protein S activity
N/A
45.3%
N/A
Free protein S
N/A
51.9%
N/A
D-dimers
N/A
2.27 mg/L
2.67 mg/L
PFA-100
231s/147s
167s/110s
N/A
An overview with gestational age-specific reference intervals can be found in
Szecsi PB et al: Haemostatic reference intervals in pregnancy. Thromb Haemost. 2010;103(4):718-727.
Comment by Rosa Sonja Alesci, MD

Von Willebrand syndrome is significantly underdiagnosed overall, as this case of a 33-year-old female patient also shows. Many sufferers have become accustomed to the symptoms and do not see a doctor. Thus, during thrombophilia screening in the context of habitual abortions, it is not uncommon for Von Willebrand syndrome to be diagnosed as an incidental finding. In the present case, especially in view of the four previous miscarriages with hemorrhage and the very impressive bleeding history, replacement of Von Willebrand factor during pregnancy was essential. In addition, the patient had to be closely monitored, especially at the beginning, since was also known to have thrombophilia. This made it possible to respond to individual circumstances and to react quickly to conspicuous complications. Overall, the present case demonstrates that recombinant Von Willebrand factor (Veyvondi®) can be successfully used in a rare type of Von Willebrand syndrome. After a history of four miscarriages, the vaginal bleeding during pregnancy was optimally treated and the birth was also without complications. No thrombotic side effects occurred and Veyvondi® could also be administered without problems in the puerperium.

See also current technical information VEYVONDI® www.swissmedicinfo.ch

Abbreviations

aPTT = activated partial thromboplastin time; FVIII:C = factor VIII activity; GI = gastrointestinal; IU = international unit; PFA-100 = Platelet Function Analyzer 100; VWF:Ag = von Willebrand factor antigen; VWF:CBA = von Willebrand factor collagen binding activity; VWF:RCo = von Willebrand factor ristocetin cofactor activity; CNS = central nervous system.

C-APROM/CH//0782  07/2020 


VEYVONDI

®

Brief technical information

Z: Active ingredient: Vonicogum alfa. I: Treatment of hemorrhage or bleeding due to surgery in the from–Willebrand–disease when therapy with desmopressin (DDAVP) alone is ineffective or contraindicated. D: Dosage and frequency must be individualized based on clinical judgment and based on patient weight, type and severity of bleeding episodes/surgical intervention, and based on monitoring of appropriate clinical and laboratory measurements; Intravenous administration. AI: Hypersensitivity to the active substance or any of the excipients. Known allergic reaction to mouse– or hamster proteins.
VM:
There are hypersensitivity– or allergic reactions occurred, which may progress to severe anaphylaxis. Monitor patients closely during infusion. Neutralizing antibodies can be formed against Von–Willebrand–Develop factor. There is a risk of thrombotic events. SS: Use only with clear indication. UW: From–Willebrand–Factor Inhibitors, Hypersensitivity– or allergic reactions, tremor, hypertension, vertigo, deep vein thrombosis, ECG changes. IA: There are no known interactions. P: Lyophilisate with 650 I.U. or 1,300 I.U. with 5 ml (resp. 10 ml for 1,300 I.E.) water for injection. Levy category B. Z: Takeda Pharma AG, 8152 Opfikon. You can find detailed information at www.swissmedicinfo.ch

Partner
  • takeda_neu_4
Autoren
  • Dr. med. Rosa Sonja Alesci
Related Topics
  • veyvondi
  • Willebrand syndrome.
Previous Article
  • Bladder Cancer

Immunotherapy after chemo may prolong survival

  • Congress Reports
  • Oncology
  • RX
  • Studies
  • Urology
View Post
Next Article
  • Inflammatory rheumatic joint diseases

Broad spectrum of differential diagnoses

  • Congress Reports
  • Education
  • General Internal Medicine
  • Geriatrics
  • Rheumatology
  • RX
View Post
You May Also Like
View Post
  • 8 min
  • Progressive multiple sclerosis

New horizons: from BTK inhibitors to remyelination

    • Education
    • Genetics
    • Neurology
    • RX
    • Studies
View Post
  • 6 min
  • Cutaneous and especially facial metastases

Rare manifestations of esophageal carcinoma

    • Cases
    • Dermatology and venereology
    • Education
    • Gastroenterology and Hepatology
    • Oncology
    • RX
    • Surgery
View Post
  • 7 min
  • Rare pulmonary syndromes

Yellow nail and Swyer-James syndrome

    • CME continuing education
    • Dermatology and venereology
    • General Internal Medicine
    • Infectiology
    • Pneumology
    • RX
View Post
  • 3 min
  • IMCAS Refresher: Aging Sciences/Plastic Surgery

Trends in aesthetic and regenerative medicine

    • Congress Reports
    • Dermatology and venereology
    • RX
    • Surgery
View Post
  • 4 min
  • Pelargonium sidoides

Scoping review sheds light on the multifaceted spectrum of effects

    • Education
    • General Internal Medicine
    • Infectiology
    • Pharmaceutical medicine
    • Phytotherapy
    • Pneumology
    • RX
    • Studies
View Post
  • 6 min
  • New evidence on genetics, pathophysiology and clinical significance

Migraine with and without aura – two different entities?

    • Education
    • General Internal Medicine
    • Neurology
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • Radiology
    • RX
    • Studies
View Post
  • 14 min
  • Prevention of skin cancer

UV protection and skin cancer screening – Update 2025

    • CME continuing education
    • Dermatology and venereology
    • Interviews
    • Oncology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 5 min
  • Case report: L. pneumophila pneumonia

Negative test results – but no alternative diagnoses

    • Cases
    • Education
    • Infectiology
    • Pneumology
    • RX
Top Partner Content
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    Yellow nail and Swyer-James syndrome
  • 2
    Individual therapy management for an optimized outcome – an update
  • 3
    Doing sport without fear or risk
  • 4
    UV protection and skin cancer screening – Update 2025
  • 5
    Rare malignancy from a dermatological perspective

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.